UNSPSC 41202057: Schistosoma spp. serological reagents

In this classification, Schistosoma genus serological reagents are devices used in test to identify specific Schistosoma genus antibodies in serum. US FDA regulates Schistosoma genus serological reagents under 21 CFR 866.3600 and under FDA product code GNH.

UNSPSC 41202057 Schistosoma spp. serological reagents is a Commodity code that in practice captures state and local procurement of diagnostic testing supplies—particularly rapid-test kits and reagents for bloodborne and sexually transmitted infection screening—rather than the narrow scope its name suggests. Recent solicitations show state and local health and criminal justice agencies purchasing HIV test kits, syphilis and gonorrhea/chlamydia (NG/CT) testing reagents, drugs-of-abuse screening supplies, and associated laboratory consumables. The issuing bodies are typically state health departments, county health services divisions, county criminal justice agencies, and municipal health programs. Illinois Department of Public Health appears as a repeat buyer, conducting both emergency sole-source procurements and competitive IFBs for Abbott-manufactured HIV and syphilis reagents; Collin County, Texas solicits across multiple related laboratory service categories; and the City of Austin has reposted a rebidded HIV test kit contract, suggesting incumbent performance issues or pricing concerns.

Recent activity clusters in Illinois, Texas, and Georgia. Illinois Department of Public Health posted an emergency notice in May 2026 for Abbott HIV/Syphilis reagents ($38,079.50), followed by a change order in September 2026 increasing quantities and cost by $375,000 for NG/CT test kits and collection supplies under an existing Hologic platform contract. Collin County, Texas issued an RFP in September 2026 for offender specimen collection and drug testing services (approximately 25,031 annual tests, $600,000 estimated value, responses due July 23, 2026). The City of Austin posted an IFB for rapid HIV test kits in June 2026 (375 Abbott test kits annually, due July 17, 2026), then reposted the same IFB as a rebid in August 2026 (due September 3, 2026). Gwinnett County, Georgia solicited drug testing supplies for an existing analyzer platform in September 2026 (proposals due October 14, 2026), though limited scope detail was disclosed. The code shows steady procurement activity driven by public health surveillance, criminal justice compliance testing, and ongoing reagent and consumable replacement cycles.